Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Xencor Inc (XNCR)

Xencor Inc (XNCR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Xencor Inc 465 NORTH HALSTEAD STREET SUITE 200 PASADENA CA 91107 USA

www.xencor.com Employees: 280 P: 626-305-5900

Description:

Xencor Inc. is a clinical-stage biopharmaceutical company. It develops antibodies for the treatment of autoimmune diseases, asthma and allergic diseases, and cancer. Xencor Inc. is based in Monrovia, California.

Key Statistics

Overview:

Market Capitalization, $K 1,686,566
Enterprise Value, $K 1,653,746
Shares Outstanding, K 69,982
Annual Sales, $ 168,340 K
Annual Net Income, $ -126,090 K
Last Quarter Sales, $ 10,710 K
Last Quarter Net Income, $ -45,140 K
EBIT, $ -217,470 K
EBITDA, $ -218,340 K
60-Month Beta 0.66
% of Insider Shareholders 5.23%
Float, K 66,322
% Float 94.77%
Short Volume Ratio 0.49

Growth:

1-Year Return 29.82%
3-Year Return -32.00%
5-Year Return -38.83%
5-Year Revenue Growth 314.63%
5-Year Earnings Growth -58.78%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.71 on 11/06/24
Next Earnings Date 11/05/24
Earnings Per Share ttm -3.20
EPS Growth vs. Prev Qtr 33.64%
EPS Growth vs. Prev Year -77.50%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

XNCR Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -30.92%
Return-on-Assets % -21.74%
Profit Margin % -74.90%
Debt/Equity 0.02
Price/Sales 9.86
Price/Cash Flow N/A
Price/Book 2.30
Book Value/Share 10.30
Interest Coverage -1.26
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar